Shanghai Pharma Enters API Market Via M&A
This article was originally published in PharmAsia News
Executive Summary
On Feb. 6 Shanghai Pharmaceuticals Holding Co. Ltd. announced its acquisition of a 70% stake in Changzhou Kony Pharma Co., Ltd. and of the remaining 30% at an agreed-upon price two years later.